Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Vaccine-Related Journal Articles

Diseases and Vaccines: Pneumococcal (PCV)

Anthrax HPV Pertussis Rubella
Chickenpox (varicella) Influenza (variant) PCV Shingles (zoster)
Diphtheria Influenza (seasonal) PPSV Smallpox
Hepatitis A Measles Polio Tetanus
Hepatitis B Meningococcus Rabies
Hib Mumps Rotavirus
PCV archive 2003-1998
Pneumococcal conjugate vaccine (PCV) 2014
Announcement: World Pneumonia Day—November 12, 2014
Source: MMWR, November 7, 2014, Vol. 63(44):1014
HTML
Declines in Pneumonia Hospitalizations of Children Aged <2 Years Associated with the Use of Pneumococcal Conjugate Vaccines—Tennessee, 1998–2012
Source: MMWR, November 7, 2014, Vol. 63(44):973-7
HTML
Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible Streptococcus pneumoniae
Authors: Dagan R, Juergens C, Trammel J, et al.
Source: J Infect Dis, e-published October 29, 2014
Abstract
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014, Vol. 63(37):822-825
HTML
National, State, and Selected Local Area Vaccination Coverage among Children Aged 19–35 Months—United States, 2013
Source: MMWR, August 29, 2014, Vol. 63(34):741-8
HTML
Pneumonia and Influenza Mortality among American Indian and Alaska Native People, 1990–2009
Authors: Groom AV, Hennessy TW, Singleton RJ, Butler JC, Holve S, Cheek JE
Source: Am J Public Health, June 2014, Vol. 104 Suppl 3:S460-9
Abstract
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
Authors: Angoulvant F, Levy C, Grimprel E, et al.
Source: Clin Infect Dis, April 2014, Vol. 58(7):918-24
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2013
Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae–Alaska, 2008-2012
Authors: Gounder PP, Bruce MG, Bruden DJ, et al.
Source: J Infect Dis, e-published December 29, 2013
Abstract
National, State, and Local Area Vaccination Coverage among Children Aged 19–35 Months — United States, 2012
Source: MMWR, September 13, 2013, Vol. 62(36):733-40
HTML
Influence of Initial Vaccination with 13-valent Pneumococcal Conjugate Vaccine or 23-valent Pneumococcal Polysaccharide Vaccine on Anti-Pneumococcal Responses following Subsequent Pneumococcal Vaccination in Adults 50 Years and Older
Authors: Jackson LA, Gurtman A, van Cleeff M, et al.
Source: Vaccine, August 2, 2013, Vol. 31(35):3594-602
Abstract
Immunogenicity and Safety of a 13-valent Pneumococcal Conjugate Vaccine in Adults 70 Years of Age and Older Previously Vaccinated with 23-valent Pneumococcal Polysaccharide Vaccine
Authors: Jackson LA, Gurtman A, Rice K, et al.
Source: Vaccine, August 2, 2013, Vol. 31(35):3585-93
Abstract
Effectiveness of Pneumococcal Conjugate Vaccine in Infants by Maternal Influenza Vaccination Status
Authors: van Santen KL, Bednarczyk RA, Adjaye-Gbewonyo D, Orenstein WA, Davis R, Omer SB
Source: Pediatr Infect Dis J, e-published July 12, 2013
Abstract
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013, Vol. 62(25):521-4
HTML
Immunogenicity and Safety of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 23-valent Pneumococcal Polysaccharide Vaccine in Pneumococcal Vaccine-Naive Adults
Authors: Jackson LA, Gurtman A, van Cleeff M, et al.
Source: Vaccine, e-published May 18, 2013
Abstract
Progress in Introduction of Pneumococcal Conjugate Vaccine−Worldwide, 2000–2012
Source: MMWR, April 26, 2013, Vol. 62(16):308-11
HTML
Cincinnati Pediatricians' Measured and Reported Immunizing Behavior for Children during the National Shortages of Pneumococcal Conjugate Vaccine
Authors: Fairbrother G, Donauer S, Staat MA, et al
Source: Vaccine, April 19, 2013, Vol. 19;31(17):2177-83
Abstract
Near Complete Elimination of the Seven Valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee
Authors: asa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W
Source: Pediatr Infect Dis J, January 23, 2013
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2012
Epidemiology of Invasive Pneumococcal Disease among High-Risk Adults since the Introduction of Pneumococcal Conjugate Vaccine for Children
Authors: Muhammad RD, Oza-Frank R, Zell E, et al.
Source: Clin Infect Dis, December 18, 2012
Abstract
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012, Vol. 61(40):816-19
HTML
The 13-Valent Pneumococcal Conjugate Vaccine for Invasive Pneumococcal Disease in Alaska Native Children: Results of a Clinical Trial
Authors: Singleton R, Wenger J, Klejka JA, et al.
Source: Pediatr Infect Dis J, September 20, 2012
Abstract
National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months--United States, 2011
Source: MMWR, September 7, 2012, Vol. 61(35):689-96
HTML
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2102, Vol. 61(21):394-5
HTML
back to top
Pneumococcal conjugate vaccine (PCV) 2011
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage among Children Aged ≤59 Months--Selected U.S. Regions, 2010-2011
Source: MMWR, November 4, 2011, Vol. 60(43):1477-81
HTML
National and State Vaccination Coverage among Children Aged 19-35 Months--United States, 2010
Source: MMWR, September 2, 2011, Vol. 60(34):1157-63
HTML
County-Level Trends in Vaccination Coverage among Children Aged 19-35 Months--United States, 1995-2008
Source: MMWR, April 29, 2011, Vol. 60(SS-04):1-86
HTML
back to top
Pneumococcal conjugate vaccine (PCV) 2010
Prevention of Pneumococcal Disease among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR Recommendations and Reports, December 10, 2010, Vol. 59(RR-11)
PDF
Parental Decline of Pneumococcal Vaccination and Risk of Pneumococcal Related Disease in Children
Authors: Glanz JM, McClure DL, O'Leary ST, et al.
Source: Vaccine, December 8, 2010
Abstract
National, State, and Local Area Vaccination Coverage among Children Aged 19--35 Months--United States, 2009
Source: MMWR, September 17, 2010, Vol. 59(36):1171-7
HTML
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Authors: Yeh SH, Gurtman A, Hurley DC, et al.
Source: Pediatrics, August 23, 2010
Abstract
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Authors: Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group
Source: Pediatrics, May 2010, Vol. 25(5):866-75
Abstract
Invasive Pneumococcal Disease in Young Children before Licensure of 13-Valent Pneumococcal Conjugate Vaccine--United States, 2007
Source: MMWR, March 12, 2010, Vol. 59(09):253-6
HTML
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010, Vol. 59(09):258-61
HTML
Invasive Pneumococcal Infections among Vaccinated Children in the United States
Authors: Park SY, Van Beneden CA, Pilishvili T, et al.
Source: J Pediatr, March 2010, Vol. 156(3):478-483.e2
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2009
The Effect of Routine Vaccination on Invasive Pneumococcal Infections in Canadian Children, Immunization Monitoring Program, Active 2000-2007
Authors: Bettinger JA, Scheifele DW, Kellner JD, et al.
Source: Vaccine, December 28, 2009
Abstract
Invasive Pneumococcal Infections among Vaccinated Children in the United States
Authors: Park SY, Van Beneden CA, Pilishvili T, et al.
Source: J Pediatr, December 2, 2009
Abstract
Cost-Effectiveness of a 3-Dose Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada
Authors: Poirier B, De Wals P, Petit G, Erickson LJ, Pépin J
Source: Vaccine, September 25, 2009
Abstract
Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America
Authors: Pickering LK, Baker CJ, Freed GL, et al.
Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40
Abstract
National, State, and Local Area Vaccination Coverage among Children Aged 19-35 Months--United States, 2008
Source: MMWR, August 28, 2009, Vol. 58(33):921-6
HTML
Immunization with the 7-Valent Conjugate Pneumococcal Vaccine: Impact Evaluation, Continuing Surveillance and Future Perspectives
Authors: Bechini A, Boccalini S, Bonanni P
Source: Vaccine, February 5, 2009
Abstract
Pneumonia Hospitalizations among Young Children Before and after Introduction of Pneumococcal Conjugate Vaccine--United States, 1997-2006
Source: MMWR, January 16, 2009, Vol. 58(01):1-4
HTML  |  PDF (entire issue)
back to top
Pneumococcal conjugate vaccine (PCV) 2008
Decreases in Case-Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995-2007: A Population-Based Study
Authors: Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM
Source: Clin Infect Dis, December 1, 2008, Vol. 47(11):1367-71
Abstract
Temporary Vaccine Recommendations and Provider Compliance: A Survey of Pediatric Practices during the 2003-2004 Pneumococcal Conjugate Vaccine Shortage
Authors: Groom H, Bhatt A, Washington ML, Santoli J
Source: Pediatrics, October 2008, Vol. 122(4):e835-40
Abstract
Indirect Effect of 7-valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members
Authors: Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL
Source: Clin Infect Dis, October 15, 2008, Vol. 47(8):989-96
Abstract
Impact of the Introduction of Pneumococcal Conjugate Vaccine on Rates of Community Acquired Pneumonia in Children and Adults
Authors: Nelson JC, Jackson M, Yu O, et al.
Source: Vaccine, September 8, 2008, Vol. 26(38):4947-54
Abstract
Changing Epidemiology of Invasive Pneumococcal Disease among White Mountain Apache Persons in the Era of the Pneumococcal Conjugate Vaccine
Authors: Lacapa R, Bliss SJ, Larzelere-Hinton F, et al.
Source: Clin Infect Dis, August 15, 2008, Vol. 47(4):476-84
Abstract
Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly with a Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age
Authors: Trofa AF, Levin M, Marchant CD, Hedrick J, Blatter MM
Source: Pediatr Infect Dis J, July 2008, Vol. 27(7):658-60
Abstract
Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United States
Authors: Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG
Source: Clin Infect Dis, June 1, 2008, Vol. 46(11):1664-72
Abstract
Safety Profile of Pneumococcal Conjugate Vaccines: Systematic Review of Pre- and Post-Licensure Data
Authors: Destefano F, Pfeifer D, Nohynek H
Source: Bull World Health Organ, May 2008, Vol. 86(5):373-80
Abstract
The Changing Epidemiology of Pneumococcal Pulmonary Disease in the Era of the Heptavalent Vaccine
Author: Lexau CA
Source: Curr Infect Dis Rep, May 2008, Vol. 10(3):229-35
Abstract
Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae among Alaskan Children
Authors: Park SY, Moore MR, Bruden DL, et al.
Source: Pediatr Infect Dis J, April 2008, Vol. 27(4):335-40
Abstract
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008, Vol. 57(13):343-4
HTML  |  PDF (entire issue)
Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children with Sickle Cell Disease in the First Decade of Life
Authors: Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM
Source: Pediatrics, March 2008, Vol. 121(3):562-9
Abstract
The Impact of Indirect (Herd) Protection on the Cost-Effectiveness of Pneumococcal Conjugate Vaccine
Authors: Isaacman DJ, Strutton DR, Kalpas EA, et al.
Source: Clin Ther, February 2008, Vol. 30(2):341-57
Abstract
Population-Based Impact of Routine Infant Immunization with Pneumococcal Conjugate Vaccine in the USA
Authors: Grijalva CG, Griffin MR
Source: Expert Rev Vaccines, February 2008, Vol. 7(1):83-95
Abstract
Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997-2004
Authors: Zhou F, Shefer A, Kong Y, Nuorti JP
Source: Pediatrics, February 2008, Vol. 121(2):253-60
Abstract
Invasive Pneumococcal Disease in Children 5 Years after Conjugate Vaccine Introduction--Eight States, 1998—2005
Author: Centers for Disease Control and Prevention
Source: MMWR, February 15, 2008, Vol. 57(06):144-8
HTML  |  PDF (entire issue)
Randomized, Controlled Trial Efficacy of Pneumococcal Conjugate Vaccine against Otitis Media among Navajo and White Mountain Apache Infants
Source: Pediatr Infect Dis J, January 2008, Vol. 27(1):71-3
Abstract
Uptake of Pneumococcal Conjugate Vaccine among Children in the 1998-2002 United States Birth Cohorts
Authors: Nuorti JP, Martin SW, Smith PJ, Moran JS, Schwartz B
Source: Am J Prev Med, January 2008, Vol. 34(1):46-53
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2007
Surveillance for Invasive Pneumococcal Disease During 2000-2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine
Authors: Black S, France EK, Isaacman D, et al
Source: Pediatr Infect Dis J, September 2007; 26(9):771-777
Abstract
National, State, and Local Area Vaccination Coverage among Children Aged 19-35 Months--United States, 2006
Source: MMWR, August 31, 2007; 56(34):880-885
HTML  |  PDF (entire issue)
Changing Characteristics of Invasive Pneumococcal Disease in Metropolitan Atlanta, Georgia, after Introduction of a 7-Valent Pneumococcal Conjugate Vaccine
Authors: Albrich WC, Baughman W, Schmotzer B, Farley MM
Source: Clin Infect Dis, June 15, 2007; 44(12):1569-1576
Abstract
Pneumococcal Bacteremia in Febrile Infants Presenting to the Emergency Department before and after the Introduction of the Heptavalent Pneumococcal Vaccine
Authors: Carstairs KL, Tanen DA, Johnson AS, Kailes SB, Riffenburgh RH
Source: Ann Emerg Med, June 2007; 49(6):772-777
Abstract
Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine
Authors: Pelton SI, Huot H, Finkelstein JA, et al
Source: Pediatr Infect Dis J, June 2007; 26:468-472
Abstract
Resurgence of the Multiresistant Pneumococcus (commentary)
Authors: Klugman KP, McGee L
Source: Pediatr Infect Dis J, June 2007; 26(6):473
Abstract
Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Antimicrobial Resistance of Invasive Streptococcus pneumoniae Isolates in Dallas, TX, Children from 1999 through 2005
Authors: Messina AF, Katz-Gaynor K, Barton T, et al
Source: Pediatr Infect Dis J, June 2007; 26(6):461-467
Abstract
Effectiveness of Pneumococcal Conjugate Vaccine in Greater Vancouver,
Canada: 2004-2005

Authors: Bjornson G, Scheifele DW, Bettinger J, et al
Source: Pediatr Infect Dis J, June 2007; 26(6):540-542
Abstract
Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes among Alaska Native Children with High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage
Authors: Singleton RJ, Hennessy TW, Bulkow LR, et al
Source: JAMA, April 25, 2007; 297(16):1784-1792
Abstract
Editorial: Invasive Pneumococcal Disease - The Target Is Moving
Authors: Peters TR, Poehling KA
Source: JAMA, April 25, 2007; 297(16):1825-1827
Abstract
WHO Position Paper: Pneumococcal Conjugate Vaccine for Childhood Immunization
Source: Weekly Epidemiological Record, March 23, 2007; 82(12): 93-104
PDF
Cost-effectiveness of Pneumococcal Conjugate Vaccination in the Prevention of Child Mortality: An international economic analysis
Authors: Sinha A, Levine O, Knoll MD, et al
Source: Lancet, February 3, 2007; 369:389-396
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2006
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48
HTML |  PDF (entire issue)
Effectiveness of Seven-Valent Pneumococcal Conjugate Vaccine against Invasive Pneumococcal Disease: A Matched Case-Control Study
Authors: Whitney CG, Pilishvili T, Farley MM, et al
Source: Lancet, October 28, 2006; 368(9546):1495-1502
Abstract
The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties
Authors: Szilagyi PG, Griffin MR, Shone LP, et al
Source: Pediatrics, October 2006, Vol. 118(4):1394-1402
Abstract
Cost-effectiveness of Pneumococcal Conjugate Vaccine: Evidence from the First 5 Years of Use in the United States Incorporating Herd Effects
Authors: Ray GT, Whitney CG, Fireman BH, et al
Source: Pediatr Infect Dis J, June 2006, Vol. 25(6):494-501
Abstract
Indirect Effect of Conjugate Vaccine on Adult Carriage of Streptococcus Pneumoniae: An Explanation of Trends in Invasive Pneumococcal Disease
Authors: Hammitt LL, Bruden DL, Butler JC, et al
Source: J Infect Dis, June 1, 2006, Vol. 193(11):1487-1494
Abstract
Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine
Authors: Stokley S, Shaw KM, Barker L, Santoli JM, Shefer A
Source: Am J Public Health, May 30, 2006 [Epub ahead of print]
Abstract
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media
Authors: Revai K, McCormick DP, Patel J, et al
Source: Pediatrics, May 2006, Vol. 117(5):1823-1829
Abstract
Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine
Authors: Poehling KA, Talbot TR, Griffin MR, et al
Source: JAMA, April 12, 2006, Vol. 295(14):1668-1674
Abstract
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-resistant Streptococcus pneumoniae
Authors: Kyaw MH, Lynfield R, Schaffner W, et al
Source: N Engl J Med, April 6, 2006, Vol. 354(14):1455-1463
Abstract
Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia
Authors: Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL.
Source: Clin Infect Dis, April 1, 2006, Vol. 42(7):907-914
Abstract
Immunogenicity, Reactogenicity and Safety of a 7-valent Pneumococcal Conjugate Vaccine (PCV7) Concurrently Administered with a DTPa-HBV-IPV/Hib Combination Vaccine in Healthy Infants
Authors: Knuf M, Habermehl P, Cimino C, et al
Source: Vaccine, March 24, 2006, [Epub ahead of print]
Abstract
Tailoring the Strategies to Specific Shortages: Pneumococcal Conjugate Vaccine
Author: Peter G
Source: Clin Infect Dis, March 1, 2006, Vol. 42 (Suppl 3):S138-S140
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2005
Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine
Authors: Lexau CA, Lynfield R, Danila R, et al
Source: JAMA, Oct. 26, 2005, Vol. 294(16):2043-2051
Abstract
Impact of Conjugate Pneumococcal Vaccines
Author: Whitney CG
Source: Pediatr Infect Dis J, August 2005, Vol. 24(8):729-730
Abstract
Who's Calling the Shots? Pediatricians' Adherence to the 2001-2003 Pneumococcal Conjugate Vaccine-Shortage Recommendations
Authors: Broder KR, MacNeil A, Malone S
Source: Pediatrics, June 2005, Vol. 115(6):1479-1487
Abstract
Accuracy of Adult Reported Pneumococcal Vaccination Status of Children
Authors: Czaja C, Crossette L, Metlay JP
Source: Ann Epidemiol, April 2005, Vol. 15(4):253-256
Abstract
Comparison of Incidence of Invasive Streptococcus Pneumoniae Disease Among Children Before and After Introduction of Conjugated Pneumococcal Vaccine
Authors: Haddy RI, Perry K, Chacko CE, et al
Source: Pediatr Infect Dis J, April 2005, Vol. 24(4):320-323
Abstract
Effect of Pneumococcal Vaccination on Quality of Life in Children with Recurrent Acute Otitis Media: A Randomized, Controlled Trial
Authors: Brouwer CN, Maille AR, Rovers MM, et al
Source: Pediatrics, Feb. 2005, Vol. 115(2):273-279
Abstract
Population-Based Surveillance for Childhood Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Authors: Hsu K, Pelton S, Karumuri S, et al
Source: Pediatr Infect Dis J, January 2005, Vol. 24(1):17-23
Abstract
back to top
Pneumococcal conjugate vaccine (PCV) 2004
Postlicensure Safety Surveillance for 7-valent Pneumococcal Conjugate Vaccine
Authors: Wise RP, Iskander J, Pratt RD, et al
Source: JAMA, October 13, 2004, Vol. 292(14):1702-1710
Abstract
Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children
Authors: Poehling KA, Lafleur BJ, Szilagyi PG, Edwards KM, Mitchel E, Barth R, Schwartz B, Griffin MR
Source: Pediatrics, September 2004, Vol. 114(3):755-761
Abstract
Cost-effectiveness Studies of Pneumococcal Conjugate Vaccines
Author: McIntosh ED
Source: Expert Rev Vaccines, August 2004, Vol. 3(4):433-442
Abstract
The Seven-Valent Pneumococcal Conjugate Vaccine Reduces Tympanostomy Tube Placement in Children
Authors: Palmu AA, Verho J, Jokinen J, et al
Source: Pediatr Infect Dis J, August 2004, Vol. 23(8):732-738
Abstract
Elimination of Racial Differences in Invasive Pneumococcal Disease in Young Children After Introduction of the Conjugate Pneumococcal Vaccine
Authors: Talbot TR, Poehling KA, Hartert TV, et al
Source: Pediatr Infect Dis J, August 2004, Vol. 23(8):726-731
Abstract
Pediatricians' Self-Reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine
Authors: Lee KC, Finkelstein JA, Miroshnik IL, et al.
Source: Archives of Pediatric and Adolescent Medicine, July 2004, Vol. 158(7):695-701
Abstract
Pneumococcal Vaccines: Do They Prevent Infection and How?
Authors: Posfay-Barbe KM, Wald ER
Source: Curr Opin Infect Dis, June 2004, Vol. 17(3):177-184
Abstract
Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser Permanente
Authors: Black S, Shinefield H, Baxter R, et al
Source: Pediatr Infect Dis J, June 2004, Vol. 23(6):485-489
Abstract
Impact of PCV7 on Invasive Pneumococcal Disease Among Children Younger than 5 Years: A Population-Based Study
Authors: Ramani RR, Hall WN, Boulton M, Johnson DR, Zhu Bao-Ping
Source: American Journal of Public Health
Abstract
Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus Pneumoniae Infections
Authors: Flannery B, Schrag S, Bennett NM, et al
Source: JAMA, May 12, 2004, Vol. 291(18):2197-2203
Abstract
Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases
Authors: O'Brien KL, Santosham M
Source: Am J Epidemiol, April 1, 2004, Vol. 159(7):634-644
Abstract
Review of Pneumococcal Conjugate Vaccine in Adults: Implications on Clinical Development
Author: Abraham-Van Parijs B
Source: Vaccine, March 29, 2004, Vol. 22(11-12):1362-1371
Abstract
Notice to Readers: Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Third and Fourth Dose
Source: MMWR, March 5, 2004, Vol. 53(8):177-178
HTML
Decrease of Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine
Authors: Kaplan SL, et al
Source: Pediatrics, March 2004, Vol. 113(3 Pt 1):443-449
Abstract
Notice to Readers: Limited Supply of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Fourth Dose
Source: MMWR, February 13, 2004, Vol. 53(05):108-109
HTML
back to top
Pneumococcal conjugate vaccine (PCV) Archive
PCV journal articles 2003-1998
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.